Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG [Phase 2]
This is a completed Phase 2 trial evaluating autologous followed by nonmyeloablative allogeneic transplantation using total lymphoid irradia…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma [Phase 1]
This update notes the completion of a Phase 1 safety study evaluating a carfilzomib, cyclophosphamide, and dexamethasone regimen given befor…
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
This study updates Phase 1/2 trial results for reduced-intensity conditioning followed by donor peripheral blood stem cell transplantation i…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 study evaluating low-dose fludarabine, busulfan, and anti-thymocyte globulin conditioning followed by donor umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of plerixafor and bortezomib in relapsed or relapsed/refractory multiple myeloma has completed wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old [Phase 3]
Phase 3 trial evaluating bortezomib, lenalidomide, and IV busulfan in patients under 65 with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 trial update of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial update for NPI-0052 in relapsed/refractory multiple myeloma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study evaluating pegylated liposomal doxorubicin hydrochloride, bortezomib, cyclophosphamide, and dexamethasone in refractory and …
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial evaluating clarithromycin plus a CTd regimen in newly diagnosed multiple myeloma; status not specified.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy [Phase 2]
Phase 2 trial evaluating romiplostim for increasing low platelet counts in multiple myeloma patients receiving chemotherapy; study terminate…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase I/II trial evaluating lenalidomide with nab-paclitaxel in relapsed/refractory multiple myeloma; the study status is terminated with …
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma [Phase 2]
A Phase 2 trial evaluated a triple-drug regimen of bevacizumab, lenalidomide, and dexamethasone in relapsed or refractory Stage II/III multi…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial update of paclitaxel albumin-stabilized nanoparticle formulation (Abraxane) in relapsed or refractory multiple myeloma; the st…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment [Phase 2]
This Phase 2 study assesses tandem autologous stem cell transplantation in multiple myeloma patients with less than 12 months of prior treat…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma [Phase 1, Phase 2]
Clinical trial update on cabozantinib (XL184) in relapsed or refractory multiple myeloma reporting Phase 1/2 results; results were posted in…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma. [Phase 2]
This Phase 2 clinical trial update assesses tolerability and efficacy of modified VCD regimens in patients with previously untreated multipl…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy followed by unrelated donor stem cell transplantation for blood and immune system cancers; …
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating elotuzumab in combination with autologous stem cell transplantation and lenalidomide maintenance in multiple myel…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study of oral LBH589 (panobinostat) in adults with advanced hematologic malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma [Phase 3]
Phase 3 trial comparing lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide in newly diagnosed multiple myelo…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant [Phase 2]
Phase 2 clinical trial update assessing safety and tolerability of HSC835 in patients with hematological malignancies undergoing single umbi…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating weekly carfilzomib in combination with dexamethasone for progressive multiple myeloma; results were p…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation [Phase 2]
Phase 2 clinical trial update evaluating upfront plerixafor in autologous transplantation and its clinical and economic impact in Non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial comparing carfilzomib-based induction (carfilzomib, melphalan, prednisone) versus bortezomib-based induction (bortezomib, melp…